Searched for
TRUMP PHARMA TARIFFS
Additional US tariffs on Indian goods since April 2025: Here’s the full timelineThe United States imposed a series of tariffs on Indian goods starting April 2025. These duties varied, with some being reciprocal and othe...- HDFC Bank, IT majors, and chemical stocks: Where Aditya Shah is hunting for value right nowGlobal markets face uncertainty due to trade tensions and geopolitical issues. Aditya Shah of Hercules Advisors advises investors to study ...
- US envoy to India meets Trump, discusses 'strong future of India-US ties'US Ambassador to India, Sergio Gor, attended a White House dinner with President Trump, discussing US-India ties and global stability. Gor ...
- Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip BandyopadhyayIndian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expe...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
- Lalitpur Pharma Park gets export push as UPSIDA, JNPA sign pactUttar Pradesh State Industrial Development Authority and Jawaharlal Nehru Port Authority have partnered. This agreement aims to make the La...
- India’s pharma exports stay resilient amid global headwinds, near $29 billion markIndian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues ...
- India largely shielded from US tariffs on patented drugs due to generic export strength: GTRINew US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...
- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Sun Pharma, Wockhardt & other pharma stocks crack up to 9% as Trump announces 100% tariff on imported patented drugsPharma stocks declined following Donald Trump's tariff announcement. Wockhardt experienced the biggest drop. Sun Pharma also hit a 52-week ...
- Trump delivers another bitter tariff pill. Who’s set to bite the dust?A new tariff announced by President Trump will impose a 100% levy on patented pharmaceuticals entering the U.S. from October 1, 2025, unles...
- Trump tariff hunt eyes India's last stock market refuge but it won't be an easy killIndian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite India's strong p...
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...
Load More
